The Boeing Company (NYSE: BA) has been awarded two contracts totaling $28,831,462.

The first contract, valued at $16,848,306, is a cost-plus-fixed-fee contract for design agent and technical engineering services. It is for the AN/USQ-82(V) family of systems, which includes the Data Multiplex System (DMS), Fiber Optic Data Multiplex System (FODMS), and Gigabit Ethernet Data Multiplex System (GEDMS). The contract also involves Foreign Military Sales to Japan, Korea, Australia, and Canada. The cumulative value of this contract could reach $99,995,070 if all options are exercised. The contracting activity is the Naval Sea Systems Command.

The second contract, worth $11,983,156, is a modification to a previously awarded contract. It is a firm-fixed-price, cost-plus-fixed-fee, and cost modification for the production of High Altitude Anti-Submarine Warfare (ASW) Weapon Capability (HAAWC) Air Launch Accessory (ALA) equipment, production support material (PSM), and related engineering and hardware support. The contracting activity for this contract is also the Naval Sea Systems Command.

On Friday, Boeing's stock ($BA) closed at $219.99, reflecting a slight increase of $0.58 (+0.26%).

Bionomics Limited (Nasdaq: BNOX), a biopharmaceutical company focused on discovering and developing innovative therapeutics, received coverage initiation from Maxim Group with a Buy rating and a price target of $7. 

Despite $BNOX closing at $2.74 on Friday, the price target suggests a potential upside of $4.26 or 155.47%, according to the boutique investment firm's analysis.

DraftKings Inc. (Nasdaq: DKNG), a leading sports betting and online gaming company, had its Overweight rating maintained by Morgan Stanley, accompanied by a price target increase from $25 to $31. 

While $DKNG closed at $24.51 on Friday, the revised price target implies a potential upside of $6.49 or 26.48%, based on the global financial services firm's perspective.

XPO, Inc. (NYSE: XPO), a global provider of transportation and logistics solutions, saw its Outperform rating maintained by BMO Capital, along with a price target raise from $55 to $60. 

Based on Friday's closing price of $51.60, the adjusted price target indicates a potential upside of $8.40 or 16.28% for $XPO, according to th investment firm's evaluation.

Equinix, Inc. (Nasdaq: EQIX), a leading provider of data center and interconnection solutions, had its Outperform rating upheld by BMO Capital, along with a price target increase from $800 to $870. 

With $EQIX closing at $778.61 on Friday, the revised price target suggests a potential upside of $91.39 or 11.74%, based on BMO Capital's assessment.

The mentioned potential upsides are derived from the perspectives of brokerage firms and analysts, providing valuable insights for evaluating investment decisions. It is important to acknowledge that actual potential upsides may vary, and investors are advised to conduct their own thorough research and analysis prior to making any investment decisions.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)